Clinical trial
Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer
NCT00002684 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002684 |
|---|---|
| Title | Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer |
| Official title | Phase II Trial of Paclitaxel, Cisplatin and Ifosfamide in Patients With Advanced Urothelial Tumors |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Urethral Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, ifosfamide, paclitaxel |
| Enrollment | 40 |
| Start date | May 1, 1995 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: